OpGen Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 77.75. In total, the insiders bought 28.08M and sold 6.43M OPGN shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
77.75
Buy 28.08M shares
Sell 6.43M shares
92% Buy Activity
Negligible or No Correlation
Buy Signal High Confidence
Jun 01, 2026

Analysis Breakdown:

  • Strongly supported by a very high Insider Power Score of 77.75.
  • Confidence increased due to high data reliability score of 100.
  • Supported by overwhelming buy-side pressure (92% buys).

Historical Insider Trades

Date Type Person Role Amount
Mar 25, 2024
Buy
Common Stock
Natan David
Director
Director 0
Value: $0
Mar 25, 2024
Buy
Common Stock
Mcmurdo Matthew Charles
Director
Director 0
Value: $0
Mar 25, 2024
Buy
Common Stock
Lazar David E.
Chief Executive Officer
CEO / President 0
Value: $0
Mar 25, 2024
Buy
Series E Convertible Preferred Stock
Lazar David E.
Chief Executive Officer
CEO / President 4 800 000
Value: $0
Mar 25, 2024
Buy
Common Stock
Ben-tzvi Avraham
Director
Director 0
Value: $0
Mar 25, 2024
Buy
Common Stock
Ben-tzvi Avraham
Director
Director 0
Value: $0
Mar 25, 2024
Buy
Series E Convertible Preferred Stock
Lazar David E.
Chief Executive Officer
CEO / President 4 800 000
Value: $0
Mar 25, 2024
Buy
Common Stock
Lazar David E.
Chief Executive Officer
CEO / President 0
Value: $0
Mar 25, 2024
Buy
Common Stock
Mcmurdo Matthew Charles
Director
Director 0
Value: $0
Mar 25, 2024
Buy
Common Stock
Natan David
Director
Director 0
Value: $0
Jun 07, 2023
Buy
Common Stock
A-Award
Schlaeppi Yvonne
Director
Director 1 500
Value: $0
Jun 07, 2023
Buy
Common Stock
A-Award
Rhodes William E.
Director
Director 1 500
Value: $0
Jun 07, 2023
Buy
Common Stock
A-Award
Fernandes Prabhavathi
Director
Director 1 500
Value: $0
Jun 07, 2023
Buy
Common Stock
A-Award
Elsey R Don
Director
Director 1 500
Value: $0
Jun 07, 2023
Buy
Common Stock
A-Award
Crovetto Mario
Director
Director 1 500
Value: $0
Jun 07, 2023
Buy
Common Stock
A-Award
Crovetto Mario
Director
Director 1 500
Value: $0
Jun 07, 2023
Buy
Common Stock
A-Award
Elsey R Don
Director
Director 1 500
Value: $0
Jun 07, 2023
Buy
Common Stock
A-Award
Fernandes Prabhavathi
Director
Director 1 500
Value: $0
Jun 07, 2023
Buy
Common Stock
A-Award
Rhodes William E.
Director
Director 1 500
Value: $0
Jun 07, 2023
Buy
Common Stock
A-Award
Schlaeppi Yvonne
Director
Director 1 500
Value: $0
Mar 31, 2023
Buy
Common Stock
M-Exempt
Bacher Johannes
Chief Operating Officer
C-Suite Officer 6 434
Value: $0
Mar 31, 2023
Buy
Restricted Stock Units
M-Exempt
Bacher Johannes
Chief Operating Officer
C-Suite Officer 6 434
Value: $0
Mar 31, 2023
Buy
Restricted Stock Units
M-Exempt
Schacht Oliver
Chief Executive Officer
CEO / President 12 469
Value: $0
Mar 31, 2023
Buy
Common Stock
M-Exempt
Schacht Oliver
Chief Executive Officer
CEO / President 12 469
Value: $0
Mar 31, 2023
Buy
Restricted Stock Units
M-Exempt
Bacher Johannes
Chief Operating Officer
C-Suite Officer 6 434
Value: $0

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT OPGEN, INC.
OpGen
OpGen, Inc., a precision medicine company, engages in developing and commercializing molecular microbiology solutions in the United States and internationally. Its product portfolio includes Acuitas AMR Gene Panel, an in vitro diagnostic (IVD) test for the detection and identification of various bacterial nucleic acids and genetic determinants of antimicrobial resistance (AMR) from bacterial colonies isolated from any specimen, as well as Curetis...
GOLDEN STAR
Ticker Change Signal Date
TPR
$140.47
0.306% Jun 04
N
NVRI
$19.53
1.79% May 20
RUN
$12.83
4.91% May 06
GLBE
$31.61
1.71% May 05
SAP
$172.39
5.53% May 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE